Connection
Matthew Greenhawt to Anaphylaxis
This is a "connection" page, showing publications Matthew Greenhawt has written about Anaphylaxis.
|
|
Connection Strength |
|
 |
|
 |
|
20.724 |
|
|
|
-
Greenhawt M. Everything you wanted to know about anaphylaxis, but were afraid to ask. Ann Allergy Asthma Immunol. 2023 08; 131(2):133-134.
Score: 0.729
-
Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, B?gin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JO, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez Del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A?GRADE assessment and international consensus approach. J Allergy Clin Immunol. 2023 08; 152(2):309-325.
Score: 0.722
-
Greenhawt M, Sindher SB, Wang J, O'Sullivan M, du Toit G, Kim EH, Albright D, Anvari S, Arends N, Arkwright PD, B?gin P, Blumchen K, Bourrier T, Brown-Whitehorn T, Cassell H, Chan ES, Ciaccio CE, Deschildre A, Divaret-Chauveau A, Dorris SL, Dorsey MJ, Eiwegger T, Erlewyn-Lajeunesse M, Fleischer DM, Ford LS, Garcia-Lloret M, Giovannini-Chami L, Hourihane JO, Jay N, Jones SM, Kerns LA, Kloepfer KM, Leonard S, Lezmi G, Lieberman JA, Lomas J, Makhija M, Parrish C, Peake J, Perrett KP, Petroni D, Pf?tzner W, Pongracic JA, Quinn P, Robison RG, Sanders G, Schneider L, Sharma HP, Trujillo J, Turner PJ, Tuttle K, Upton JE, Varshney P, Vickery BP, Vogelberg C, Wainstein B, Wood RA, Bee KJ, Campbell DE, Green TD, Rouissi R, Peillon A, Bahnson HT, Bois T, Sampson HA, Burks AW. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
Score: 0.718
-
Greenhawt M. Is epinephrine truly lifesaving, and can we prove this? Ann Allergy Asthma Immunol. 2023 08; 131(2):279-282.
Score: 0.715
-
Greenhawt M, Lieberman JA, Dribin TE, Shaker MS, Spergel J. Retire the advice to send patients to the emergency department after epinephrine use for observation. Ann Allergy Asthma Immunol. 2023 06; 130(6):697-698.
Score: 0.703
-
Picard M, Stone CA, Greenhawt M. Management of patients with immediate reactions to COVID-19 vaccines. J Allergy Clin Immunol. 2023 02; 151(2):413-415.
Score: 0.685
-
Greenhawt M, Abrams EM, Chalil JM, Tran O, Green TD, Shaker MS. The Impact of Allergy Specialty Care on Health Care Utilization Among Peanut Allergy Children in the United States. J Allergy Clin Immunol Pract. 2022 Dec; 10(12):3276-3283.
Score: 0.682
-
Chu DK, Abrams EM, Golden DBK, Blumenthal KG, Wolfson AR, Stone CA, Krantz MS, Shaker M, Greenhawt M. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. JAMA Intern Med. 2022 04 01; 182(4):376-385.
Score: 0.665
-
Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, Bernstein J, Bingemann T, Blumchen K, Byrne A, Bognanni A, Campbell D, Campbell R, Chagla Z, Chan ES, Chan J, Comberiati P, Dribin TE, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Grayson MH, Horner CC, Hourihane J, Katelaris CH, Kim H, Kelso JM, Lang D, Ledford D, Levin M, Lieberman J, Loh R, Mack D, Mazer B, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Oppenheimer J, Perrett KP, Ramsey A, Rank M, Robertson K, Sheikh J, Spergel JM, Stukus D, Tang MLK, Tracy JM, Turner PJ, Whalen-Browne A, Wallace D, Wang J, Waserman S, Witry JK, Worm M, Vander Leek TK, Golden DBK. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
Score: 0.630
-
Shaker M, Greenhawt M. Partnering with Patients and Communities to Improve Prehospital Anaphylaxis Care. J Allergy Clin Immunol Pract. 2021 06; 9(6):2334-2335.
Score: 0.628
-
Hourihane JO, Byrne AM, Bl?mchen K, Turner PJ, Greenhawt M. Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines. J Allergy Clin Immunol Pract. 2021 07; 9(7):2562-2566.
Score: 0.624
-
Shaker M, Phillips E, Blumenthal KG, Abrams EM, Banerji A, Oppenheimer J, Vander Leek TK, Mack DP, Wickner PG, Singer AG, Khan DA, Greenhawt M. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
Score: 0.623
-
Shaker M, Abrams EM, Greenhawt M. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies. J Allergy Clin Immunol Pract. 2021 07; 9(7):2658-2668.e3.
Score: 0.618
-
Greenhawt M, Abrams EM, Oppenheimer J, Vander Leek TK, Mack DP, Singer AG, Shaker M. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
Score: 0.613
-
Shaker M, Turner PJ, Greenhawt M. A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy-One Epinephrine Autoinjector or Two? J Allergy Clin Immunol Pract. 2021 06; 9(6):2440-2451.e3.
Score: 0.612
-
Abrams EM, Greenhawt M. The role of peanut-free school policies in the protection of children with peanut allergy. J Public Health Policy. 2020 Jun; 41(2):206-213.
Score: 0.586
-
Chan ES, Dinakar C, Gonzales-Reyes E, Green TD, Gupta R, Jones D, Wang J, Winders T, Greenhawt M. Unmet needs of children with peanut allergy: Aligning the risks and the evidence. Ann Allergy Asthma Immunol. 2020 05; 124(5):479-486.
Score: 0.572
-
Shaker M, Wallace D, Golden DBK, Oppenheimer J, Greenhawt M. Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis. JAMA Netw Open. 2019 10 02; 2(10):e1913951.
Score: 0.559
-
Greenhawt M, Oppenheimer J, Shaker M. Fearing the Bark That Has No Bite: Parsing Practical From Theoretical Risk. Ann Allergy Asthma Immunol. 2019 10; 123(4):327-328.
Score: 0.559
-
Shaker M, Greenhawt M. Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis. JAMA Netw Open. 2019 05 03; 2(5):e193242.
Score: 0.543
-
Greenhawt M, Gupta RS, Meadows JA, Pistiner M, Spergel JM, Camargo CA, Simons FER, Lieberman PL. Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel Consensus. J Allergy Clin Immunol Pract. 2019 04; 7(4):1148-1156.e5.
Score: 0.534
-
Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
Score: 0.534
-
Shaker M, Kanaoka T, Feenan L, Greenhawt M. An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis. Ann Allergy Asthma Immunol. 2019 01; 122(1):79-85.
Score: 0.514
-
Shaker M, Greenhawt M. The Health and Economic Outcomes of Peanut Allergy Management Practices. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2073-2080.
Score: 0.507
-
Greenhawt M, Wallace D, Sublett JW, Maughan E, Tanner A, Kelley KJ, Fineman S, White M, Cash G, Anderson C, Schoessler S, Gupta R, Pistiner M. Current trends in food allergy-induced anaphylaxis management at school. Ann Allergy Asthma Immunol. 2018 08; 121(2):174-178.
Score: 0.506
-
Greenhawt M, DunnGalvin A. Preliminary psychometric analyses and clinical performance of a caregiver self-efficacy scale for food allergy self-management. Ann Allergy Asthma Immunol. 2018 01; 120(1):73-79.
Score: 0.495
-
Waserman S, Avilla E, Ben-Shoshan M, Rosenfield L, Adcock AB, Greenhawt M. Epinephrine Autoinjectors: New Data, New?Problems. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1180-1191.
Score: 0.484
-
Greenhawt MJ. Establishing the safety of influenza vaccine in egg-allergic individuals. Pediatr Ann. 2013 Jul; 42(7):122-7.
Score: 0.362
-
Greenhawt M, Rubenstein JH. A tailored vs empiric diet--which is best for eosinophilic esophagitis? Gastroenterology. 2013 Jun; 144(7):1560-1.
Score: 0.358
-
Greenhawt MJ, Singer AM, Baptist AP. Food allergy and food allergy attitudes among college students. J Allergy Clin Immunol. 2009 Aug; 124(2):323-7.
Score: 0.275
-
Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol. 2007 Oct; 7(5):387-92.
Score: 0.243
-
Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Abrams EM, Bernstein JA, Chu DK, Horner CC, Rank MA, Stukus DR, Burrows AG, Cruickshank H, Golden DBK, Wang J, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Waserman S, Abrams EM, Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Rank MA, Shaker MS, Stukus DR, Wang J. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 02; 132(2):124-176.
Score: 0.187
-
Shaker MS, Golden DBK, Lieberman JA, Greenhawt M, Lee MW. Inhaled epinephrine for anaphylaxis: Time for another look? Ann Allergy Asthma Immunol. 2024 03; 132(3):267-269.
Score: 0.187
-
Giovannini M, Foong RX, Greenhawt M, du Toit G. "Playing possum": The potential importance of neurological clinical manifestations occurring during anaphylaxis in infants and toddlers. Pediatr Allergy Immunol. 2023 07; 34(7):e13989.
Score: 0.181
-
Gold MS, Amarasinghe A, Greenhawt M, Kelso JM, Kochhar S, Yu-Hor Thong B, Top KA, Turner PJ, Worm M, Law B. Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine. 2023 04 06; 41(15):2605-2614.
Score: 0.174
-
Alqurashi W, Shaker M, Wells GA, Collins GS, Greenhawt M, Curran JA, Zemek R, Schuh S, Ellis A, Gerdts J, Kreviazuk C, Dixon A, Eltorki M, Freedman SB, Gravel J, Poonai N, Worm M, Plint AC. Canadian Anaphylaxis Network-Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): a prospective, cohort study protocol. BMJ Open. 2022 10 31; 12(10):e061976.
Score: 0.173
-
Chen G, DunnGalvin A, Greenhawt M, Shaker M, Campbell DE. Deriving health utility indices from a food allergy quality-of-life questionnaire. Pediatr Allergy Immunol. 2021 11; 32(8):1773-1780.
Score: 0.159
-
Abrams EM, Greenhawt M, Alqurashi W, Singer AG, Shaker M. The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go. J Allergy Clin Immunol Pract. 2021 11; 9(11):3911-3917.
Score: 0.157
-
Waserman S, Cruickshank H, Hildebrand KJ, Mack D, Bantock L, Bingemann T, Chu DK, Cuello-Garcia C, Ebisawa M, Fahmy D, Fleischer DM, Galloway L, Gartrell G, Greenhawt M, Hamilton N, Hourihane J, Langlois M, Loh R, Muraro A, Rosenfield L, Schoessler S, Tang MLK, Weitzner B, Wang J, Brozek JL. Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines. J Allergy Clin Immunol. 2021 05; 147(5):1561-1578.
Score: 0.156
-
Mack DP, Chan ES, Shaker M, Abrams EM, Wang J, Fleischer DM, Hanna MA, Greenhawt M. Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change. J Allergy Clin Immunol Pract. 2020 10; 8(9):2851-2857.
Score: 0.148
-
Greenhawt M, Shaker M, Stukus DR, Fleischer DM, Hourihane J, Tang MLK, Abrams EM, Wang J, Bingemann TA, Chan ES, Lieberman J, Sampson HA, Bock SA, Young MC, Waserman S, Mack DP. Managing Food Allergy in Schools During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 10; 8(9):2845-2850.
Score: 0.148
-
Shaker M, McWilliams S, Greenhawt M. Update on penicillin allergy delabeling. Curr Opin Pediatr. 2020 04; 32(2):321-327.
Score: 0.145
-
Shaker MS, Oppenheimer J, Wallace DV, Golden DBK, Lang DM, Lang ES, Bernstein JA, Campbell RL, Chu D, Dinakar C, Ellis AK, Greenhawt M, Horner C, Lieberman JA, Rank MA, Stukus DR, Wang J. Making the GRADE in anaphylaxis management: Toward recommendations integrating values, preferences, context, and shared decision making. Ann Allergy Asthma Immunol. 2020 06; 124(6):526-535.e2.
Score: 0.144
-
Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, Dinakar C, Ellis A, Greenhawt M, Khan DA, Lang DM, Lang ES, Lieberman JA, Portnoy J, Rank MA, Stukus DR, Wang J, Riblet N, Bobrownicki AMP, Bontrager T, Dusin J, Foley J, Frederick B, Fregene E, Hellerstedt S, Hassan F, Hess K, Horner C, Huntington K, Kasireddy P, Keeler D, Kim B, Lieberman P, Lindhorst E, McEnany F, Milbank J, Murphy H, Pando O, Patel AK, Ratliff N, Rhodes R, Robertson K, Scott H, Snell A, Sullivan R, Trivedi V, Wickham A, Shaker MS, Wallace DV, Shaker MS, Wallace DV, Bernstein JA, Campbell RL, Dinakar C, Ellis A, Golden DBK, Greenhawt M, Lieberman JA, Rank MA, Stukus DR, Wang J, Shaker MS, Wallace DV, Golden DBK, Bernstein JA, Dinakar C, Ellis A, Greenhawt M, Horner C, Khan DA, Lieberman JA, Oppenheimer J, Rank MA, Shaker MS, Stukus DR, Wang J. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 04; 145(4):1082-1123.
Score: 0.143
-
Toy D, Braga MS, Greenhawt M, Shaker M. An update on allergic emergencies. Curr Opin Pediatr. 2019 06; 31(3):426-432.
Score: 0.137
-
Greenhawt M. Pearls and pitfalls of food challenges in infants. Allergy Asthma Proc. 2019 01 01; 40(1):62-69.
Score: 0.133
-
Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol. 2017 08; 119(2):164-169.
Score: 0.120
-
Howe L, Franxman T, Teich E, Greenhawt M. What affects quality of life among caregivers of food-allergic children? Ann Allergy Asthma Immunol. 2014 Jul; 113(1):69-74.e2.
Score: 0.097
-
Franxman TJ, Greenhawt MJ, Baldwin JL. Recurrent perioperative anaphylaxis in a 54-year-old man. Allergy Asthma Proc. 2013 Jul-Aug; 34(4):383-386.
Score: 0.091
-
Greenhawt MJ, Spergel JM, Rank MA, Green TD, Mansoor D, Masnoor D, Sharma H, Bird JA, Chang JE, Parikh DS, Sinh D, Teich E, Kelso JM, Sanders GM. Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy. Ann Allergy Asthma Immunol. 2012 Dec; 109(6):426-30.
Score: 0.086
-
Jacobs TS, Greenhawt MJ, Hauswirth D, Mitchell L, Green TD. A survey study of index food-related allergic reactions and anaphylaxis management. Pediatr Allergy Immunol. 2012 Sep; 23(6):582-9.
Score: 0.084
-
Greenhawt MJ, Li JT, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Ann Allergy Asthma Immunol. 2011 Jan; 106(1):11-6.
Score: 0.076
-
Greenhawt MJ, Chernin AS, Howe L, Li JT, Sanders G. The safety of the H1N1 influenza A vaccine in egg allergic individuals. Ann Allergy Asthma Immunol. 2010 Nov; 105(5):387-93.
Score: 0.075
-
Greenhawt M, McMorris M, Baldwin J. Carmine hypersensitivity masquerading as azithromycin hypersensitivity. Allergy Asthma Proc. 2009 Jan-Feb; 30(1):95-101.
Score: 0.066
-
Abrams EM, Greenhawt M, Shaker M, Alqurashi W. Separating Fact from Fiction in the Diagnosis and Management of Food Allergy. J Pediatr. 2022 02; 241:221-228.
Score: 0.040
-
Howe LE, Conlon AS, Greenhawt MJ, Sanders GM. Safe administration of seasonal influenza vaccine to children with egg allergy of all severities. Ann Allergy Asthma Immunol. 2011 May; 106(5):446-7.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|